Exploring access to medicinal cannabis through general practitioners in Australia

Although stigma and demographic access barriers to MC are decreasing with cultural, industry and healthcare system shifts, inequitable access is still occurring due to the economic burden on patients. GPs reported having difficulties in navigating the prescribing process and accessing the most up-to-date evidence for clinical use due to time scarcity.